tirzepatide y semaglutide Understand the Difference between and Maintenance therapy on semaglutide or

These are usually mild and subside over time

Three medications represent this progression: Semaglutide (single agonist, 15% average weight loss), Tirzepatide (dual agonist, 22.5% weight loss), and Retatrutide (triple agonist, 28.7% weight loss)

Taken together, these findings suggest that alleviation of the weight loss and inflammatory exacerbation associated with UC resulted in a significant decline in mortality in the Si-DSS group compared with that in the Con-DSS group (Table 1)

doi: 10.1007/978-3-030-74180-8_10

If pregnancy occurs while taking semaglutide, inform your OB-GYN immediatelydiscontinuation is recommended, but brief exposure is not considered a medical emergency

Variants in the GLP1R gene (rs6923761) and the GIPR gene (rs1800437) influence how strongly your body responds to GLP-1 signaling, affecting both weight loss and side-effect severity